Insulin action during variable hyperglycemic-hyperinsulinemic infusions in hyperandrogenic anovulatory patients and healthy women

Daniel A. Dumesic, David H. Abbott, Joel R. Eisner, K Sreekumaran Nair, Robert A. Rizza

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: To determine whether 3-month GnRH analogue (GnRH-a) administration to hyperandrogenic anovulatory patients and healthy women affects glucose utilization or endogenous glucose production (EGP) in the postabsorptive state and during variable hyperglycemic-hyperinsulinemic infusions.Design: Prospective, nonrandomized study.Setting: Academic research environment.Patient(s): Twelve hyperandrogenic anovulatory patients and 11 healthy women matched by body mass index and waist to hip circumference ratio.Intervention(s): Variable hyperglycemic-hyperinsulinemic infusions replicated physiological increases in circulating glucose and insulin levels before and after 3-month GnRH-a administration.Main outcome measure(s): Glucose utilization and EGP.Result(s): In the postabsorptive state, plasma glucose and insulin levels, glucose utilization, and EGP were similar in hyperandrogenic patients and healthy women. During variable hyperglycemic-hyperinsulinemic infusions, glucose use increased and EGP decreased to similar degrees in both groups of women. Three-month GnRH-a administration to hyperandrogenic patients and healthy women did not affect plasma glucose and insulin levels, glucose utilization and EGP in the postabsorptive state, or glucose utilization and EGP during variable hyperglycemic-hyperinsulinemic infusions.Conclusion(s): Glucose use and EGP in the postabsorptive state and during variable hyperglycemic-hyperinsulinemic infusions are similar in hyperandrogenic anovulatory patients and healthy women of similar body fat distribution and are unaffected by 3-month GnRH-a administration. Copyright (C) 1999 American Society for Reproductive Medicine.

Original languageEnglish (US)
Pages (from-to)458-466
Number of pages9
JournalFertility and Sterility
Volume72
Issue number3
DOIs
StatePublished - Sep 1999
Externally publishedYes

Fingerprint

Insulin
Glucose
Gonadotropin-Releasing Hormone
Body Fat Distribution
Waist-Hip Ratio
Body Mass Index
Outcome Assessment (Health Care)
Prospective Studies

Keywords

  • Androgens
  • Hyperandrogenic anovulation
  • Insulin resistance

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Insulin action during variable hyperglycemic-hyperinsulinemic infusions in hyperandrogenic anovulatory patients and healthy women. / Dumesic, Daniel A.; Abbott, David H.; Eisner, Joel R.; Nair, K Sreekumaran; Rizza, Robert A.

In: Fertility and Sterility, Vol. 72, No. 3, 09.1999, p. 458-466.

Research output: Contribution to journalArticle

Dumesic, Daniel A. ; Abbott, David H. ; Eisner, Joel R. ; Nair, K Sreekumaran ; Rizza, Robert A. / Insulin action during variable hyperglycemic-hyperinsulinemic infusions in hyperandrogenic anovulatory patients and healthy women. In: Fertility and Sterility. 1999 ; Vol. 72, No. 3. pp. 458-466.
@article{e16ca8f4f20f4436bb290ea6c8b4ddbc,
title = "Insulin action during variable hyperglycemic-hyperinsulinemic infusions in hyperandrogenic anovulatory patients and healthy women",
abstract = "Objective: To determine whether 3-month GnRH analogue (GnRH-a) administration to hyperandrogenic anovulatory patients and healthy women affects glucose utilization or endogenous glucose production (EGP) in the postabsorptive state and during variable hyperglycemic-hyperinsulinemic infusions.Design: Prospective, nonrandomized study.Setting: Academic research environment.Patient(s): Twelve hyperandrogenic anovulatory patients and 11 healthy women matched by body mass index and waist to hip circumference ratio.Intervention(s): Variable hyperglycemic-hyperinsulinemic infusions replicated physiological increases in circulating glucose and insulin levels before and after 3-month GnRH-a administration.Main outcome measure(s): Glucose utilization and EGP.Result(s): In the postabsorptive state, plasma glucose and insulin levels, glucose utilization, and EGP were similar in hyperandrogenic patients and healthy women. During variable hyperglycemic-hyperinsulinemic infusions, glucose use increased and EGP decreased to similar degrees in both groups of women. Three-month GnRH-a administration to hyperandrogenic patients and healthy women did not affect plasma glucose and insulin levels, glucose utilization and EGP in the postabsorptive state, or glucose utilization and EGP during variable hyperglycemic-hyperinsulinemic infusions.Conclusion(s): Glucose use and EGP in the postabsorptive state and during variable hyperglycemic-hyperinsulinemic infusions are similar in hyperandrogenic anovulatory patients and healthy women of similar body fat distribution and are unaffected by 3-month GnRH-a administration. Copyright (C) 1999 American Society for Reproductive Medicine.",
keywords = "Androgens, Hyperandrogenic anovulation, Insulin resistance",
author = "Dumesic, {Daniel A.} and Abbott, {David H.} and Eisner, {Joel R.} and Nair, {K Sreekumaran} and Rizza, {Robert A.}",
year = "1999",
month = "9",
doi = "10.1016/S0015-0282(99)00265-4",
language = "English (US)",
volume = "72",
pages = "458--466",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Insulin action during variable hyperglycemic-hyperinsulinemic infusions in hyperandrogenic anovulatory patients and healthy women

AU - Dumesic, Daniel A.

AU - Abbott, David H.

AU - Eisner, Joel R.

AU - Nair, K Sreekumaran

AU - Rizza, Robert A.

PY - 1999/9

Y1 - 1999/9

N2 - Objective: To determine whether 3-month GnRH analogue (GnRH-a) administration to hyperandrogenic anovulatory patients and healthy women affects glucose utilization or endogenous glucose production (EGP) in the postabsorptive state and during variable hyperglycemic-hyperinsulinemic infusions.Design: Prospective, nonrandomized study.Setting: Academic research environment.Patient(s): Twelve hyperandrogenic anovulatory patients and 11 healthy women matched by body mass index and waist to hip circumference ratio.Intervention(s): Variable hyperglycemic-hyperinsulinemic infusions replicated physiological increases in circulating glucose and insulin levels before and after 3-month GnRH-a administration.Main outcome measure(s): Glucose utilization and EGP.Result(s): In the postabsorptive state, plasma glucose and insulin levels, glucose utilization, and EGP were similar in hyperandrogenic patients and healthy women. During variable hyperglycemic-hyperinsulinemic infusions, glucose use increased and EGP decreased to similar degrees in both groups of women. Three-month GnRH-a administration to hyperandrogenic patients and healthy women did not affect plasma glucose and insulin levels, glucose utilization and EGP in the postabsorptive state, or glucose utilization and EGP during variable hyperglycemic-hyperinsulinemic infusions.Conclusion(s): Glucose use and EGP in the postabsorptive state and during variable hyperglycemic-hyperinsulinemic infusions are similar in hyperandrogenic anovulatory patients and healthy women of similar body fat distribution and are unaffected by 3-month GnRH-a administration. Copyright (C) 1999 American Society for Reproductive Medicine.

AB - Objective: To determine whether 3-month GnRH analogue (GnRH-a) administration to hyperandrogenic anovulatory patients and healthy women affects glucose utilization or endogenous glucose production (EGP) in the postabsorptive state and during variable hyperglycemic-hyperinsulinemic infusions.Design: Prospective, nonrandomized study.Setting: Academic research environment.Patient(s): Twelve hyperandrogenic anovulatory patients and 11 healthy women matched by body mass index and waist to hip circumference ratio.Intervention(s): Variable hyperglycemic-hyperinsulinemic infusions replicated physiological increases in circulating glucose and insulin levels before and after 3-month GnRH-a administration.Main outcome measure(s): Glucose utilization and EGP.Result(s): In the postabsorptive state, plasma glucose and insulin levels, glucose utilization, and EGP were similar in hyperandrogenic patients and healthy women. During variable hyperglycemic-hyperinsulinemic infusions, glucose use increased and EGP decreased to similar degrees in both groups of women. Three-month GnRH-a administration to hyperandrogenic patients and healthy women did not affect plasma glucose and insulin levels, glucose utilization and EGP in the postabsorptive state, or glucose utilization and EGP during variable hyperglycemic-hyperinsulinemic infusions.Conclusion(s): Glucose use and EGP in the postabsorptive state and during variable hyperglycemic-hyperinsulinemic infusions are similar in hyperandrogenic anovulatory patients and healthy women of similar body fat distribution and are unaffected by 3-month GnRH-a administration. Copyright (C) 1999 American Society for Reproductive Medicine.

KW - Androgens

KW - Hyperandrogenic anovulation

KW - Insulin resistance

UR - http://www.scopus.com/inward/record.url?scp=0033198731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033198731&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(99)00265-4

DO - 10.1016/S0015-0282(99)00265-4

M3 - Article

C2 - 10519617

AN - SCOPUS:0033198731

VL - 72

SP - 458

EP - 466

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 3

ER -